Literature DB >> 9422734

Dominant-negative c-Jun NH2-terminal kinase 2 sensitizes renal inner medullary collecting duct cells to hypertonicity-induced lethality independent of organic osmolyte transport.

P A Wojtaszek1, L E Heasley, G Siriwardana, T Berl.   

Abstract

The c-Jun NH2-terminal protein kinases (JNKs), as well as the extracellular signal-regulated protein kinases (ERKs) and p38 mitogen-activated protein kinase, are activated in renal cells in response to extracellular hypertonicity. To determine whether activation of JNKs by hypertonicity is isoform-specific, renal inner medullary collecting duct cells were stably transfected with cDNA's encoding hemagglutinin (HA)-tagged JNK1 and JNK2 isoforms, and the expressed kinases were immunoprecipitated with an anti-HA antibody. Whereas both recombinant kinases were equivalently expressed, only immunoprecipitates from the HA-JNK2 cells displayed hypertonicity-inducible JNK activity. Furthermore, expression of dominant-negative JNK2 (HA-JNK2-APF) in stable clones inhibited hypertonicity-induced JNK activation by 40-70%, whereas expression of dominant-negative JNK1 (HA-JNK1-APF) had no significant inhibitory effect. Independent HA-JNK2-APF (but not HA-JNK1-APF) clones displayed greatly reduced viability relative to neomycin controls after 16 h of exposure to 600 mosM/kg hypertonic medium with percent survival of 20.5 +/- 2.7 and 31.5 +/- 7.3 for two independent HA-JNK2-APF clones compared with 80.1 +/- 1.0 for neomycin controls (p < 0.001, n = 5, mean +/- S.E.). However, neither JNK mutant blocked either regulatory volume increase or hypertonicity-induced enhancement of uptake of inositol, an organic osmolyte putatively involved in long term adaptation to hypertonicity. These results define JNK2 as the primary hypertonicity-activated JNK isoform in IMCD-3 cells and demonstrate its central importance in cellular survival in a hypertonic environment by a mechanism independent of acute regulatory volume increase as well as regulation of organic osmolyte uptake.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9422734     DOI: 10.1074/jbc.273.2.800

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

1.  Stress- and cell type-dependent regulation of transfected c-Jun N-terminal kinase and mitogen-activated protein kinase kinase isoforms.

Authors:  L Butterfield; E Zentrich; A Beekman; L E Heasley
Journal:  Biochem J       Date:  1999-03-15       Impact factor: 3.857

2.  Inhibiting JNK dephosphorylation and induction of apoptosis by novel anticancer agent NSC-741909 in cancer cells.

Authors:  Xiaoli Wei; Wei Guo; Shuhong Wu; Li Wang; Yiling Lu; Bo Xu; Jinsong Liu; Bingliang Fang
Journal:  J Biol Chem       Date:  2009-05-04       Impact factor: 5.157

3.  The c-Jun NH2-terminal kinase 2 plays a dominant role in human epidermal neoplasia.

Authors:  Hengning Ke; Rebecca Harris; Jonathan L Coloff; Jane Y Jin; Benjamin Leshin; Paula Miliani de Marval; Shiying Tao; Jeffrey C Rathmell; Russell P Hall; Jennifer Y Zhang
Journal:  Cancer Res       Date:  2010-03-30       Impact factor: 12.701

4.  Activation of c-Jun NH2-terminal kinase is required for gemcitabine's cytotoxic effect in human lung cancer H1299 cells.

Authors:  Fuminori Teraishi; Lidong Zhang; Wei Guo; Fengqin Dong; John J Davis; Anning Lin; Bingliang Fang
Journal:  FEBS Lett       Date:  2005-11-14       Impact factor: 4.124

5.  p38 MAP kinase modulates liver cell volume through inhibition of membrane Na+ permeability.

Authors:  A P Feranchak; T Berl; J Capasso; P A Wojtaszek; J Han; J G Fitz
Journal:  J Clin Invest       Date:  2001-11       Impact factor: 14.808

6.  c-Jun N-terminal kinase promotes stem cell phenotype in triple-negative breast cancer through upregulation of Notch1 via activation of c-Jun.

Authors:  X Xie; T S Kaoud; R Edupuganti; T Zhang; T Kogawa; Y Zhao; G B Chauhan; D N Giannoukos; Y Qi; D Tripathy; J Wang; N S Gray; K N Dalby; C Bartholomeusz; N T Ueno
Journal:  Oncogene       Date:  2016-12-12       Impact factor: 9.867

7.  Kit signaling through PI 3-kinase and Src kinase pathways: an essential role for Rac1 and JNK activation in mast cell proliferation.

Authors:  I Timokhina; H Kissel; G Stella; P Besmer
Journal:  EMBO J       Date:  1998-11-02       Impact factor: 11.598

8.  The signals of FGFs on the neurogenesis of embryonic stem cells.

Authors:  Ching-Wen Chen; Chin-San Liu; Ing-Ming Chiu; Shih-Cheng Shen; Hung-Chuan Pan; Kun-Hsiung Lee; Shinn-Zong Lin; Hong-Lin Su
Journal:  J Biomed Sci       Date:  2010-04-29       Impact factor: 8.410

9.  Multiple kinase cascades mediate prolactin signals to activating protein-1 in breast cancer cells.

Authors:  Jennifer H Gutzman; Debra E Rugowski; Matthew D Schroeder; Jyoti J Watters; Linda A Schuler
Journal:  Mol Endocrinol       Date:  2004-08-19

Review 10.  How do kidney cells adapt to survive in hypertonic inner medulla?

Authors:  Tomas Berl
Journal:  Trans Am Clin Climatol Assoc       Date:  2009
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.